FindTrial
Sign In

A New Strategy of Anesthesia and Analgesia for Intraspinal Tumor Surgery with Intravenous Lidocaine

A New Strategy of Anesthesia and Analgesia for Intraspinal Tumor Surgery with Intravenous Lidocaine

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900021134
Enrollment
Unknown
Registered
2019-01-29
Start date
2019-02-11
Completion date
Unknown
Last updated
2020-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intraspinal Tumor

Interventions

Group 1:routine anesthesia scheme + intravenous lidocaine
Group 2:routine anesthesia scheme

Sponsors

Department of Anesthesiology, Beijing Tian Tan Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients who underwent surgery for thoracolumbar intraspinal tumors were enrolled in the study. Selection criteria: American Society of Anesthesiologists (ASA) Grade I - I I, aged 18 - 65.

Exclusion criteria

Exclusion criteria: 1) history of drug abuse, psychiatric disorders and obesity (>130% of standard body weight); 2) cardiovascular diseases and unstable hypertension; 3) communication disorders; 4) contraindications of propofol, opioids and lidocaine (e.g. allergy, cardiac conduction block, porphyria); 5) inability to use patient-controlled analgesia device (PCA pump) [unable to understand the use of the device].

Design outcomes

Primary

MeasureTime frame
VAS;Pain threshold;Electrophysiological monitoring indicators;—

Countries

China

Contacts

Public ContactWeihua Cui

Department of Anesthesiology, Beijing Tian Tan Hospital, Capital Medical University

13651315600@139.com+86 13651315600

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026